Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-10T16:43:23.261Z Has data issue: false hasContentIssue false
  • English
  • Français

Nutritional support in patients with advanced cancer: permission to fall out?

Published online by Cambridge University Press:  07 March 2007

A. W. McKinlay
A. W. McKinlay*
Affiliation:
Gastrointestinal Unit, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK
*
Corresponding author: Dr A. McKinlay, fax +44 1224 550711, email a.w.mckinlay@arh.grampian.scot.nhs.uk
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Data from the European Society for Parenteral and Enteral Nutrition Home Artificial Nutrition Survey suggest that the use of home parenteral nutrition (HPN) in patients with cancer as the primary diagnosis varies markedly between different countries in Europe, being highest in The Netherlands and low in the UK. This finding is difficult to explain on the basis of cancer incidence. The main indication for HPN remains malignant gastrointestinal tract obstruction, which occurs most frequently in gynaecological and colon cancers. The use of HPN should be planned in the light of the proposed cancer treatment and should be discussed beforehand with the patient. Before HPN is considered, a patient should typically require intravenous fluids to maintain hydration, be capable of self care, be able to control the treatment, have an expected survival of ≥3 months and have no other available route of feeding. The effect of HPN on quality of life remains controversial, but nutrition is only one of the factors that influence the quality of life in cancer patients. The differing rates of HPN in Europe are probably related to cultural attitudes to incurable cancer as much as to meeting the nutritional needs of the patient.

Keywords

Advanced cancerMalignant gastrointestinal obstructionHome parenteral nutritionQuality of life
Type
BAPEN Symposium 2: Nutrition in palliative care
Information
Proceedings of the Nutrition Society , Volume 63 , Issue 3 , August 2004 , pp. 431 - 435
Copyright
Copyright © The Nutrition Society 2004

References

Bakker, H, Bozzetti, F, Staun, M, Leon-Sanz, M, Hebuterne, X, Pertkiewicz, M, Shaffer, J & Thul, P (1999) Home parenteral nutrition in adults: a european multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group. Clinical Nutrition 18, 135–140.Google Scholar
Barrera, R (2002) Nutritional support in cancer patients. Journal of Parenteral and Enteral Nutrition 26, S63–S71.Google Scholar
Bozzetti, F (2003) Home total parenteral nutrition in incurable cancer patients: a therapy, a basic humane care or something in between?. Clinical Nutrition 22, 109–111.Google Scholar
Bozzetti, F, Cozzaglio, L, Biganzoli, E, Chiavenna, G, De Cicco, M, Donati, D, Gilli, G, Percolla, S & Pironi, L (2002) Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clinical Nutrition 21, 281–288.Google Scholar
Bozzetti, F, Gavazzi, C, Miceli, R, Rossi, N, Mariani, L, Cozzaglio, L, Bonfanti, G & Piacenza, S (2000) Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. Journal of Parenteral and Enteral Nutrition 24, 7–14.Google Scholar
Bray, F, Sankila, R, Ferlay, J & Parkin, DM (2002) Estimates of cancer incidence and mortality in Europe in 1995. European Journal of Cancer 38, 99–166.Google Scholar
Buchman, AL (2002) Must every cancer patient die with a central venous catheter? (comment). Clinical Nutrition 21, 269–271.Google Scholar
Department of Health (2003) Better hospital food. http://patientexperience.nhsestates.gov.uk/bhf/bhf_content/home/home.asp Google Scholar
Hardy, G & Campos, A (2003) Editorial comment: if patients prefer parenteral nutrition; is enteral nutrition failing to deliver?. Current Opinion in Clinical Nutrition and Metabolic Care 6, 307–311.Google Scholar
Karnofsky, DA, Abelman, WH, Craver, LF & Burchenal, JH (1948) The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1, 634.Google Scholar
King, LA, Carson, LF, Konstantinides, N, House, MS, Adcock, LL, Prem, KA, Twiggs, LB & Cerra, FB (1993) Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?. Gynecologic Oncology 51, 377–382.Google Scholar
Klein, S, Kinney, J, Jeejeebhoy, K, Alpers, D, Hellerstein, M, Murray, M & Twomey, P (1997) Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. American Journal of Clinical Nutrition 66, 683–706.Google Scholar
Klein, S & Koretz, RL (1994) Nutrition support in patients with cancer: what do the data really show? Nutrition in Clinical Practice 9, 91–100.Google Scholar
NHS Quality Improvement Scotland (2003) Standard for Hospital Food, Fluid and Nutritional Care in Hospitals. Edinburgh: NHS QIS.Google Scholar
Ripamonti, C & Bruera, E (2002) Palliative management of malignant bowel obstruction. International Journal of Gynecological Cancer 12, 135–143.Google Scholar
Schattner, M (2003) Enteral nutritional support of the patient with cancer: route and role. Journal of Clinical Gastroenterology 36, 297–302.Google Scholar
Spears, H, Petrelli, NJ, Herrera, L & Mittelman, A (1988) Treatment of bowel obstruction after operation for colorectal carcinoma. American Journal of Surgery 155, 383–386.Google Scholar
Weiss, SM, Worthington, PH, Prioleau, M & Rosato, FE (1982) Home total parenteral nutrition in cancer patients. Cancer 50, 1210–1213.Google Scholar